» Articles » PMID: 31624106

Vitamin K-dependent Carboxylation of Coagulation Factors: Insights from a Cell-based Functional Study

Overview
Journal Haematologica
Specialty Hematology
Date 2019 Oct 19
PMID 31624106
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Vitamin K-dependent carboxylation is a post-translational modification essential for the biological function of coagulation factors. Defects in carboxylation are mainly associated with bleeding disorders. With the discovery of new vitamin K-dependent proteins, the importance of carboxylation now encompasses vascular calcification, bone metabolism, and other important physiological processes. Our current knowledge of carboxylation, however, comes mainly from studies carried out under artificial conditions, which have a limited usefulness in understanding the carboxylation of vitamin K-dependent proteins in native conditions. Using a recently established mammalian cell-based assay, we studied the carboxylation of coagulation factors in a cellular environment. Our results show that the coagulation factor's propeptide controls substrate binding and product releasing during carboxylation, and the propeptide of factor IX appears to have the optimal affinity for efficient carboxylation. Additionally, non-conserved residues in the propeptide play an important role in carboxylation. A cell-based functional study of naturally occurring mutations in the propeptide successfully interpreted the clinical phenotype of warfarin's hypersensitivity during anticoagulation therapy in patients with these mutations. Unlike results obtained from studies, results from our cell-based study indicate that although the propeptide of osteocalcin cannot direct the carboxylation of the coagulation factor, it is required for the efficient carboxylation of osteocalcin. This suggests that the coagulation factors may have a different mechanism of carboxylation from osteocalcin. Together, results from this study provide insight into efficiently controlling one physiological process, such as coagulation without affecting the other, like bone metabolism.

Citing Articles

Vitamin K Properties in Stroke and Alzheimer's Disease: A Janus Bifrons in Protection and Prevention.

Grimaldi L, Cavallaro R, De Angelis D, Fuso A, Sancesario G Molecules. 2025; 30(5).

PMID: 40076254 PMC: 11901974. DOI: 10.3390/molecules30051027.


Multiplex, multimodal mapping of variant effects in secreted proteins.

Popp N, Powell R, Wheelock M, Holmes K, Zapp B, Sheldon K bioRxiv. 2025; .

PMID: 39975210 PMC: 11838247. DOI: 10.1101/2024.04.01.587474.


Molecular basis of vitamin-K-driven γ-carboxylation at the membrane interface.

Cao Q, Ammerman A, Saimi M, Lin Z, Shen G, Chen H Nature. 2025; .

PMID: 39880037 DOI: 10.1038/s41586-025-08648-1.


Exploring micronutrients and microbiome synergy: pioneering new paths in cancer therapy.

Bhatnagar K, Jha K, Dalal N, Patki N, Gupta G, Kumar A Front Immunol. 2024; 15:1442788.

PMID: 39676876 PMC: 11638209. DOI: 10.3389/fimmu.2024.1442788.


PharmVar GeneFocus: CYP4F2.

Zubiaur P, Rodriguez-Antona C, Boone E, Daly A, Tsermpini E, Khasawneh L Clin Pharmacol Ther. 2024; 116(4):963-975.

PMID: 39135485 PMC: 11452279. DOI: 10.1002/cpt.3405.


References
1.
Wu S, Chen X, Jin D, Stafford D, Pedersen L, Tie J . Warfarin and vitamin K epoxide reductase: a molecular accounting for observed inhibition. Blood. 2018; 132(6):647-657. PMC: 6085993. DOI: 10.1182/blood-2018-01-830901. View

2.
Camire R, Larson P, Stafford D, High K . Enhanced gamma-carboxylation of recombinant factor X using a chimeric construct containing the prothrombin propeptide. Biochemistry. 2000; 39(46):14322-9. DOI: 10.1021/bi001074q. View

3.
Jorgensen M, Cantor A, Furie B, Brown C, Shoemaker C, Furie B . Recognition site directing vitamin K-dependent gamma-carboxylation resides on the propeptide of factor IX. Cell. 1987; 48(2):185-91. DOI: 10.1016/0092-8674(87)90422-3. View

4.
Bristol J, Ratcliffe J, Roth D, Jacobs M, Furie B, Furie B . Biosynthesis of prothrombin: intracellular localization of the vitamin K-dependent carboxylase and the sites of gamma-carboxylation. Blood. 1996; 88(7):2585-93. View

5.
Baker P, Clarke K, Giangrande P, Keeling D . Ala-10 mutations in the factor IX propeptide and haemorrhage in a patient treated with warfarin. Br J Haematol. 2000; 108(3):663. DOI: 10.1046/j.1365-2141.2000.01901.x. View